Viewing nowEzetimibe 10 mg Tablets (Ezetimibe)
Ezetimibe 10mg
Tablet · Prescription medication
Kookjoo Pharmaceutical Co., Ltd.

MFDS item code 201902782 · Approved 2019.04.30 · Insurance code 669805380
Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia
This medication helps to lower cholesterol and other lipid levels in patients with primary hypercholesterolemia, mixed hyperlipidemia, homozygous familial hypercholesterolemia, and homozygous sitosterolemia. In particular, it is used in conjunction with diet or with other lipid-lowering therapies to control total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and other lipid levels. This medication is also used to manage lipid levels in patients at high risk for cardiovascular disease. It is important to identify and treat secondary causes such as diabetes and hypothyroidism before use, and to monitor treatment efficacy through regular lipid testing. Thus, this medication effectively improves various lipid abnormalities associated with hypercholesterolemia.
A standard cholesterol-lowering diet should be continued while taking this medicine. The recommended dose of this medicine is 10 mg once daily, and it may be taken with or without food. When administered in combination with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate combination therapy with this medicine at the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medicine concomitantly while maintaining the HMG-CoA reductase inhibitor dose. When this medicine is administered in combination with fenofibrate (in patients with mixed dyslipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use 4. General Precautions). No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use 2. Administration with Caution in the Following Patients). No dose adjustment is necessary in patients with renal impairment. No dose adjustment is necessary when administering this medicine to elderly patients. This medicine should be administered 2 hours before or 4 hours after administration of a bile acid sequestrant (see Precautions for Use 5. Drug Interactions).
This medication should not be used in patients allergic to specific ingredients. Patients with active liver disease or persistently elevated liver enzyme levels of unknown cause should not combine this medication with statins. It is safe for pregnant or nursing women not to take this medication in conjunction with statins or fenofibrate. Patients with severe liver dysfunction or gallbladder disease or severe kidney dysfunction should not take this medication with fenofibrate. This medication contains lactose, so it should not be taken by patients with lactose intolerance or certain genetic metabolic disorders. Patients with moderate to severe liver dysfunction may have increased exposure to this medication, so its use is not recommended. Generally, this medication is safe, but side effects such as headache, abdominal pain, diarrhea, fatigue, and muscle pain may occur, so caution is advised. If used in conjunction with statins, there is a possibility of elevated liver enzymes, so liver function tests should be performed regularly. If symptoms of muscle pain or weakness appear, inform a doctor immediately and discontinue use. Patients with severe kidney impairment may take this medication without dose adjustment, but those with decreased kidney function should be closely monitored according to a doctor's instructions. This medication may interact with other drugs, so caution is necessary when taken with cholestyramine, fibrates, cyclosporine, anticoagulants, etc. Women who are pregnant or of childbearing potential should consult a doctor before using this medication, and breastfeeding should also be avoided. Children under 6 years of age are recommended not to take this medication, while children and adolescents over 6 years should use it under medical guidance. Older adults can also take it, but some may be more sensitive to the medication, so caution is needed. In cases of overdose, there is no specific antidote, so appropriate treatment should be obtained based on symptoms, and it should be kept out of reach of children.
Fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, joint pain, low back pain, cough, chest pain, dizziness, headache, constipation, bloating, nausea, elevated AST, elevated ALT, myalgia, myopathy, rhabdomyolysis, elevated aminotransferase levels, gallbladder-related adverse reactions, cholelithiasis, cholecystitis, anaphylaxis, urticaria, rash, angioedema, elevated creatine phosphokinase levels, hepatitis, thrombocytopenia, pancreatitis, sensory disturbances, depression, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms associated with drug reactions, erythema multiforme, drug-induced liver injury, chest discomfort, malaise, edema, fatigue, generalized edema, diabetic neuropathy, tremors, epigastric pain, vomiting, gastritis, xerostomia, discomfort in the epigastric region, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, conjunctival injection, renal failure, liver function abnormalities, increased serum creatinine, increased blood pressure, increased blood urea, increased serum creatine phosphokinase, abnormal liver function tests, dyspepsia, nausea
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a sealed container. Additionally, it is best to store the medication at room temperature between 1 degree and 30 degrees Celsius, away from extremes of heat or cold.
White to almost white rectangular tablets
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEzetimibe 10mg
Tablet · Prescription medication
Kookjoo Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Shin Il Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.